IntrinsicIntrinsic
← Scroll for more →

Financial Statements — PCMC

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2021
Cash & Equivalents0.010.020.070.230.230.240.080.100.100.040.050.060.060.000.000.000.00
Accounts Receivable----0.170.030.03------------------------
Total Current Assets0.010.020.26--0.27------------------------
Property, Plant & Equipment------0.000.00------0.00----------------
Total Non-current Assets*0.000.000.00--0.00------------------------
Total Assets0.010.020.260.270.270.240.080.100.100.040.050.060.000.000.000.000.00
Accounts Payable0.030.030.030.030.030.020.020.020.020.010.010.010.010.010.020.020.02
Short-term Debt--------0.450.400.180.18------------------
Total Current Liabilities0.330.310.480.470.470.860.670.670.500.560.560.560.480.480.470.470.46
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities0.330.310.480.470.470.860.670.670.500.560.560.560.480.480.470.470.46
Retained Earnings(5.85)(5.83)(5.75)(5.74)(5.74)(5.67)(5.65)(5.63)(5.63)(5.58)(5.56)(5.55)(5.53)(5.53)(5.52)(5.52)(5.51)
Total Stockholder Equity(0.32)(0.30)(0.22)(0.21)(0.21)(0.62)(0.60)(0.57)(0.40)(0.53)(0.51)(0.50)(0.48)(0.48)(0.47)(0.46)(0.46)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in thousands USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2021
Research & Development0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00
Selling, General & Admin24.5624.5616.3528.0723.2423.2423.7128.3111.3216.508.8915.271.303.705.043.3412.74
Total Operating Expenses24.5624.5616.3528.0723.2423.2423.7128.3111.3216.508.8915.271.303.705.043.3412.74
Operating Income(24.56)(24.56)(16.35)(28.07)(23.24)(23.24)(23.71)(28.31)(11.32)(16.50)(8.89)(15.27)(1.30)(3.70)(5.04)(3.34)(12.74)
Interest Expense0.000.882.632.632.632.632.632.632.632.632.632.632.632.632.632.632.63
Net Income(24.56)(24.56)(17.02)(30.46)(25.86)(25.86)(26.34)(30.93)(13.94)(19.12)(11.52)(17.90)(3.92)(6.32)(7.66)(5.97)(15.37)
Basic EPS0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00
Diluted EPS0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2021
Operating Cash Flow(8.36)(56.50)(32.85)(64.57)(20.74)(56.46)(23.85)(25.71)(9.82)(15.00)(8.20)(18.25)(0.04)(1.35)(1.04)(2.20)
Investing Cash Flow0.000.00(130.00)--------------------------
Financing Cash Flow275.00--------225.00--------------------
← Scroll for more columns →